Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3).
Novel heteroarotinoids as potential antagonists of Mycobacterium bovis BCG.
Synthesis and characterization of heteroarotinoids demonstrate structure specificity relationships.
Synthesis of potential metabolites of ethyl (E)-4-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzopyran-6-yl)-1-propenyl] benzoate.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel heteroarotinoids as potential antagonists of Mycobacterium bovis BCG.
Novel heteroarotinoids as potential antagonists of Mycobacterium bovis BCG. J Med Chem. 2004 Feb 12; 47(4):1008-17.
View in:
PubMed
subject areas
Benzoates
Benzopyrans
Microbial Sensitivity Tests
Mycobacterium bovis
Retinoids
Structure-Activity Relationship
Thiourea
authors with profiles
Doris M Benbrook
Kenneth Darrell Berlin